The studies:
In preclinical studies, the treatment of insulin-resistant, obese rhesus monkeys with 19 resulted in a 79% increase in HDL, a 56% decrease in TG, and a 29% decrease in LDL-C [101,102].
Treatment of Apcmin mice, which are predisposed to colon polyp formation, with a PPARδ agonist...